1st Xarelto MDL Bellwether Trial Ends In Defense Verdict For Bayer, Janssen

(May 4, 2017, 1:24 PM EDT) -- NEW ORLEANS — The first Xarelto multidistrict litigation bellwether trial ended May 3 with a defense verdict for co-defendants Janssen Pharmaceuticals Inc. and Bayer Pharma AG (In Re:  Xarelto Products Liability Litigation, MDL Docket No. 2592, No. 14-md-2592, Joseph Boudreaux Jr., et al. v. Janssen Pharmaceuticals, Inc., et al., No. 14-2720, E.D. La.)....

Attached Documents

Related Sections